Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-26 @ 3:15 PM
NCT ID: NCT07338292
Eligibility Criteria: Inclusion Criteria: * Male/female with age ≥ 18 years * Patient who are undergoing one of the interventions mentioned in the study for the first time; * Eligibility for minimally invasive ambulatory urological procedures, possibly requiring vascular access (circumcision, prostate biopsy, flexible cystoscopy); * Ability to understand instructions and complete study questionnaires; * Signed informed consent. Exclusion Criteria: * Absolute contraindications to the planned urological procedure (e.g., active urinary tract infection, anatomical urethral abnormalities); * Recent urological manipulations (e.g., urethral dilation, bladder biopsy, insertion or removal of a double-J stent); * Medical contraindications to the use of virtual reality, including uncontrolled photosensitive epilepsy and relevant neurological, ophthalmologic, or otolaryngologic disorders; * Presence of severe psychiatric disorders or major cardiovascular diseases that may interfere with study participation; * Previous adverse reactions to virtual reality exposure; * Use of analgesic medications within 24 hours prior to the procedure; * Use of drugs that may alter consciousness or impair the ability to complete psychological assessments; * Severe communication disabilities or significant hearing impairment that would prevent completion of questionnaires.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 99 Years
Study: NCT07338292
Study Brief:
Protocol Section: NCT07338292